1. Home
  2. |Insights
  3. |VA Consolidates Fraud Detection, Prevention, and Enforcement Efforts

VA Consolidates Fraud Detection, Prevention, and Enforcement Efforts

Client Alert | 1 min read | 06.08.17

Continuing the Trump Administration’s focus on fraud, waste, and abuse, Veterans Affairs Secretary Dr. David Shulkin announced a program to consolidate fraud detection, prevention, and remediation efforts in VA administered programs. The program, called Seek to Prevent Fraud, Waste, and Abuse (STOP FWA), consolidates fraud prevention and remediation efforts within VA health, benefits, and cemeteries programs and is expected to partner with other federal agencies to leverage best practice in fraud prevention, detection, and enforcement. Information sharing among fraud detection and remediation programs has accelerated in recent years across the government, and contractors are well served to consider a holistic approach to investigating (and, if needed, disclosing) misconduct because it is increasingly likely that multiple government stakeholders will be interested in the outcome.

Insights

Client Alert | 9 min read | 10.21.26

Artificial Intelligence in Life Sciences: Reliability of AI-Generated Evidence in Drug Discovery and Development

The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .  ...